External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- University of Maryland, Baltimore
- Study ID
- NCT07053098
- Status
- Recruiting
Conditions
- Alcohol-Related Disorders
- Psychiatric Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Implementation Facilitation — OTHERImplementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.
Study Details
This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.
Key Dates
- Start date
- Mar 18, 2025
- Status verified
- May 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Implementation FacilitationThis Implementation Facilitation Intervention will include external facilitation, staff training, patient education, audit and feedback, and care coordination.
Primary Outcome Measure
Prescribing medications for alcohol use disorder [ Time Frame: 6 months after the end of implementation facilitation ]
Central Contacts
- Melanie Bennett, PhD410-706-2490
- Brian Brandler410-706-2490
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Maryland Baltimore | Baltimore | Maryland | 21201 | Brian Brandler Melanie Bennett (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Baltimore, MD
By research site
Related Studies
- Characterization Imaging Instruments in Alcoholics and Non-AlcoholicsRecruiting · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Bethesda, Maryland
- Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver TransplantationEnrolling By Invitation · Johns Hopkins University · Baltimore, Maryland
- COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History StudyRecruiting · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Bethesda, Maryland
- Diclofenac Dose Response StudyPHASE1 · Recruiting · University of Maryland, Baltimore · Catonsville, Maryland